Laura Heitman Group

GPCR, allosteric modulation, target binding kinetics, small molecules

Our Focus

In the Heitman group, we combine different expertise and research domains, such as molecular biology, pharmacology, organic and computational chemistry. We have selected G protein-coupled receptors (GPCRs), a superfamily of membrane-bound proteins, as study objects, as many drugs act via these. Although it is clear that GPCRs also have a role in cancer, little is known about the mechanisms they are involved in, and thus how to best target them (at a receptor-level). Using this membrane protein class, our research focus is on so called “Novel receptor concepts”, with the ultimate aim to make medicines work better. Two such concepts are ‘Allosteric modulation’ and ‘Drug-target binding kinetics’, which can both lead to so-called insurmountable antagonism, i.e. antagonists that cannot be disrupted/counteracted by high local concentrations of the endogenous receptor agonist that is often causal to the disease state. This includes endogenous agonists for GPCRs involved in cancer, and thus these “novel receptor concepts” are potentially highly valuable for drug discovery in this disease area.

Cas van der Horst Research Technician
Chenlin Feng Phd Candidate
Daan van der Es Assistant Professor
Huub Sijben Phd Student
Inge Snijders Phd Student
Jara Bouma Phd Candidate
Khaled Essa Phd Student
Lisa Den Hollander Phd Student
Marina Gorostiola Gonzalez Phd Student
Natalia Ortiz Phd Student
Rongfang Liu Technician
Xuesong Wang Phd Student
Yao Yao Phd Student
Contact Information
Laura Heitman Oncode Investigator

More Research

Research Strategy
Focus and Approach
Over 800 scientists working under a single strategy. Oncode is all about uniting efforts and bringing focus to research.
Support Programme
Our supporting programmes
New plans that help fulfil Oncode's objectives get our full support. Young talents are matched with mentors on the basis of their personal endeavours.